Institutional Ownership Theseus Pharmaceuticals, Inc. (THRX)
This table provides information about the institutional ownership of Theseus Pharmaceuticals, Inc. (THRX). We have compiled data on the 2 institutions that hold shares in the stock, with a total of 1.03 Million shares, which have been reported (via 13F filing form) to have a value of $0.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Foresite Capital Opportunity Management V, LLC
Larkspur, CA |
Nov 14, 2022 Q3 2022 |
959,275
shares
|
$0
16.71% of portfolio
|
Q2 2022
Added 104.61%
|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
75,000
shares
|
$0
0.03% of portfolio
|
Q1 2023
Reduced 25.0%
|